Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks; changes in polymer consumption growth rates where the Company conducts business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters, including any developments that would require any increase in the Company’s costs and/or reserves for such contingencies; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; the speed and extent of an economic recovery, including the recovery of the housing markets; the financial condition of the Company’s customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; disruptions, uncertainty or volatility in the credit markets that may limit the Company’s access to capital; other factors affecting the Company’s business beyond the Company’s control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation; the Company’s ability to realize anticipated savings and operational benefits from the realignment of assets, including the planned closure of certain manufacturing facilities; the timing of closings and shifts of production to new facilities related to asset realignments and any unforeseen disruptions of service or quality caused by such closings and/or production shifts; the timing of the recognition of the charges that will be incurred; separation and severance amounts and plant exit costs that differ from original estimates; amounts for non-cash charges related to asset write-offs, asset impairments, and accelerated depreciation realignments of property, plant and equipment, that differ from original estimates; the Company’s ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired companies into the Company’s operations, retain the management teams of acquired companies, and retain relationships with customers of acquired companies, including, without limitation, Spartech Corporation; and other factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2013 under Item 1A, “Risk Factors.”

PRODUCT BULLETIN VERSAFLEX™ GP 2810-40N AM VERSAFLEX™ CE 3120-65* AM ONFLEX™ LO 7120-45 AM Applications Personal care grips Consumer packaging Consumer electronics Charging stations HVAC seals Cup holder mats Color Natural Natural Natural Durometer, Shore A 45 66 45 Specific Gravity (kg/m3) 0.87 1.14 1.13 Tensile Strength (PSI) 650 1200 585 Elongation % 700 600 685 Modulus @ 300% |(PSI) 260 585 300 Injection Moldable Yes Yes Yes OM Substrate PP PC, ABS, PC/ABS, COPE PP TECHNICAL PROPERTIES *UL listing does not apply; testing can be completed if required by the customer Copyright © 2021, Avient Corporation.

DEVICE MANUFACTURER M E D I C A L D E V I C E H O U S I N G • Improved chemical resistance compared to PC/ABS, PC/PET & COPE • Flame retardant (FR) rating of V-1 at 0.75 mm • Zero BPA & non-halogenated FR material • Available in standard hospital grade pre-colors • Provided a cost-effective material with superior chemical resistance to traditional materials • Formulated a medical-grade, semi-crystalline blend to support regulatory testing and approvals • Demonstrated superior property retention and crack resistance after exposure to hospital- grade disinfectants, including Virex® Tb, helping to extend the device life Trilliant™ HC8900 Thermoplastics KEY REQUIREMENTS WHY AVIENT?

SBD cordless power tool GLOBAL CLOUD SERVICE PROVIDER I N T E R N A L H O L D O F S E R V E R C A B I N E T S • PC-based solution with good impact strength • UL 94 V-0 certification • Dimensionally stable • Offered a 40% glass fiber-reinforced PC solution with high modulus and high impact strength • Achieved a UL 94 V-0 flammability rating at 3.0 mm • Provided pre-colored formulation that met specific white requirements and maintained good color stability even after long-term production at high temperatures • Ensured high flowability so the material could be injected with low pressure, avoiding damage to the metal frame Edgetek Engineered Polymer Formulations KEY REQUIREMENTS WHY AVIENT?

Trilliant™ HC high performance formulations were developed for specific healthcare enclosure needs, including: • Chemical resistance to common disinfectants • UL 94 ratings of 5VA at 3.0, V-0 at 1.5 mm & V-1 at 0.75 mm • Retained color aesthetics after chemical exposure • Ability to utilize existing PC/PET & COPE tooling Tested using an adaptation from ASTM D543 for environmental stress cracking resistance (ESCR), 15 bars of each material were placed into jigs at 1% and 2% strain. Virex® Tb Vesphene™ IIse CaviCide™ Trilliant™ HC 8910 +++ +++ +++ Trilliant™ HC 8920 (FR) – +++ +++ FR PC/PET – + ++ FR COPE (copolyester) + ++ +++ Tensile Strength Property Retention After 72-hour Continuous Exposure +++ Best (>90% retention), ++ Better (50-90% retention), + Good ( Designed for two- shot injection molding and formulated for the appropriate substrate, these medical-grade TPEs are compatible with rigid PVC, copolyesters, all PC alloys, ABS, TPUs and PEI substrates.

Concentrates and pre-colored formulations are available for a wide range of polymers, including PE, PP, PEBA, PC, ABS, and others. KEY CHARACTERISTICS • Globally harmonized formulations are manufactured at four ISO 13485 certified medical sites, providing global consistency and increased security of supply • Documented change control available • A range of standard colors eliminates color matching to expedite development time • The portfolio includes compliant colors for use in: - Needle hub applications: ISO 6009 - Ophthalmic container closures (American Academy of Ophthalmology) REGULATORY SUPPORT • A library of pre-tested raw materials including: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* HEALTHCARE APPLICATIONS • Medical devices such as catheters, surgical and dental instruments, and drug delivery devices • Pharmaceutical packaging including vials and bottles • Diagnostics for blood analysis or In Vitro Diagnostics (IVD) PRODUCT BULLETIN & COLOR CARD * FDA/EU compliance information available upon request; exceptions may occur Color Pantone Reference PE Base PP Base Transparent PP Base PEBA Base PC Base Transparent PC Base* ABS Base* White — PE0M176031 PP0M176045 ** AH0M415001 NC0M176058 ** SB0M665206 Yellow 102C PE1M176076 PP1M176060 PP1M176062 AH1M415002 NC1M176058 NC1M176059 SB1M664958 Orange 158C PE2M176044 PP2M176046 ** ** NC2M176044 NC2M664912 SB2M664939 Red 199C PE3M176131 PP3M176111 PP3M176113 AH3M415002 NC3M176116 NC3M176122 SB3M665037 Pink 196C PE3M176130 PP3M176109 ** AH3M415001 NC3M176117 NC3M665052 SB3M665039 Violet 2593C PE4M176023 PP4M176036 PP4M176039 AH4M415001 NC4M176038 NC4M176044 SB4M664978 Light Blue 292C PE5M176155 PP5M176169 ** AH5M415003 NC5M176142 ** SB5M665402 Mid Blue 285C PE5M176154 PP5M176171 PP5M176175 AH5M415002 NC5M176143 NC5M176146 SB5M665404 Dark Blue 288C PE5M176153 PP5M176173 ** ** NC5M176144 ** SB5M665406 Light Green 346C PE6M176128 PP6M176111 ** ** NC6M176118 ** SB6M665070 Bluish Green 3145C PE6M176126 PP6M176115 ** ** NC6M176119 ** SB6M665068 Medium Green 348C PE6M176127 PP6M176113 PP6M176118 AH6M415001 NC6M176120 NC6M176121 SB6M665072 Dark Gray 425C PE7M176066 PP7M176091 PP7M176094 ** NC7M176124 ** SB7M665297 Mid Gray Cool Gray 5C PE7M176067 PP7M176089 ** AH7M415001 NC7M176125 NC7M665175 SB7M665295 Beige 7502C PE8M176048 PP8M176058 ** ** NC8M176058 ** SB8M664871 Brown 463C/731C PE8M176049 PP8M176060 ** ** NC8M176059 ** SB8M664869 Black Black C PL9M176008 PP9M176017 ** ** NC9M176008 NC9M176009 SB9M664896 Colors may vary from actual color shown.

KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number reducing risk of change • Non-phthalate and formulated without animal- derived substances • Available for use in a wide range of polymers including polyolefins, styrenics, polycarbonate and alloys, polyester, POM • Functionality can be combined with colorants into convenient combination concentrates and ready-to-use formulations REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request FUNCTIONALITY TARGET APPLICATIONS DRUG DELIVERY DEVICES SYRINGES & NEEDLES DIAGNOSTICS CATHETERS Clarifying PP Sorbitol-free for transparent applications with reduced migration and improved thermal stability     Lubricant— permanent/ non-migrating Fast acting reduction in friction for wide variety of polymers such as PP, ABS, POM, PC    Protection from UV in transparent applications for PP, PE, PETG, COP UV blocking in 290-450nm with no impact on clarity; can be combined with colors (e.g., amber)   Antistatic ready-to- use solution for PP, ABS, PC/ABS Permanent/non-migrating; fast decay time independent of % relative humidity  Gamma/e-beam sterilization protection of the polymer Preserving the properties of PP and COC/COP; reduction in yellowing using Color Compensation Technology (CCT)    Reduced material consumption/cycle time—nucleation Fast acting new generation nucleant for PE and PP; improved thermal and mechanical properties allows wall thinning; reduction of tolerance/dimensional problems between different colors    Laser marking replacing ink printing/labels Solvent-free, high-speed identification for Nd/YAG laser for PE,PP, ABS, PC, POM     Antioxidants for PE, PP, TPE Thermal protection during converting/downstream sterilization    Brand protection/ anticounterfeit Covert and non-covert systems   Healthcare use limitations apply—see below.

Requirements: Excellent clarity, scratch resistance and exceptional toughness for visualization of medicant levels Solution: Avient Distribution HC Portfolio: Acrylic, copolyester, PC 2. Requirements: Excellent clarity, scratch resistance and exceptional toughness Solution: Avient Distribution HC Portfolio: Acrylic, copolyester, PC, clarified PP Visual Identification Use colors and additives to differentiate and identify your brand, product or batch. Requirements: Light diffusing optical properties Solution: Avient Distribution HC Portfolio: Light diffusing acrylics, PC 16.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include our ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired businesses into our operations, such as Magna Colours, retain the management teams of acquired businesses, and retain relationships with customers of acquired businesses; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; information systems failures and cyberattacks; and amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions. View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-expands-sustainable-solutions-portfolio-with-acquisition-of-magna-colours-ltd-301324100.html

Originally from the View original content:http://www.prnewswire.com/news-releases/polyone-announces-leadership-appointments-301024927.html